Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptides for Hearing Loss: Comparison & Mechanisms

Before relying on any peptide for auditory research, understanding how each compound differs mechanistically matters significantly. Thymalin Immune modulation via T-cell rebalancing, reduces inflammatory cytokines (TNF-alpha, IL-1beta) in autoimmune inner ear

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before relying on any peptide for auditory research, understanding how each compound differs mechanistically matters significantly.
  • Thymalin
  • Immune modulation via T-cell rebalancing, reduces inflammatory cytokines (TNF-alpha, IL-1beta) in autoimmune inner ear disease
  • Autoimmune SSNHL, inflammatory-mediated loss
  • Animal models + limited human case series
  • Most relevant for immune-driven acute loss; narrow application but well-documented in that context
  • BPC-157
  • VEGF upregulation, angiogenesis, tissue repair, promotes endothelial migration and capillary density
  • Age-related presbycusis (vascular), noise trauma (tissue repair)
  • Strong animal data, no human hearing trials
  • Biological plausibility is high for vascular-mediated loss; lack of clinical validation is the limitation
  • Cerebrolysin
  • Neurotrophic peptide blend mimicking BDNF/NGF, supports spiral ganglion neuron survival and synaptic maintenance
  • Noise-induced, ototoxic (prevents neuronal degeneration)
  • Rodent models show 25–35% threshold shift reduction post-trauma
  • Best evidence for acute protective use; unclear if beneficial in chronic established loss
  • P21 (CNTF fragment)
  • Antioxidant, reduces oxidative stress and apoptosis in cochlear hair cells
  • Ototoxic drug exposure (cisplatin, aminoglycosides)
  • In vitro and animal models
  • Narrow preventive role during chemotherapy or antibiotic use; not regenerative
  • Dihexa
  • HGF/Met pathway activation, synaptic density restoration in auditory brainstem
  • Central auditory processing deficits, cochlear synaptopathy
  • Animal studies in aged rats
  • Targets central processing, not peripheral hair cell loss. Different mechanism from others